Welcome to the Schizophrenia Resource Centre

Welcome, this website is intended for healthcare professionals in EMEA with an interest in the treatment of schizophrenia. By clicking the link below you are declaring and confirming that you are a healthcare professional

You are here

Targeting microglia activation in schizophrenia by minocycline treatment

Interview with Dr. Susanne A. Wolf, Max-Delbrück-Center in the Helmholtz Association. Berlin, Germany

PROF_ Wolf | V1-HD 1080p

The importance of the microglia has gained a lot of attention recently, as a novel therapeutic target in psychiatric disorders. Prof. Wolf discusses her group’s findings, which indicate that the tetracycline antibiotic minocycline affects specific microglial functions and thereby attenuates symptoms of schizophrenia in an animal model.